BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7827173)

  • 1. Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium.
    Porter AT; Ben-Josef E; Davis L
    Curr Opin Oncol; 1994 Nov; 6(6):607-10. PubMed ID: 7827173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioisotopes in the treatment of bone metastases.
    Ben-Josef E; Porter AT
    Ann Med; 1997 Feb; 29(1):31-5. PubMed ID: 9073322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
    Bauman G; Charette M; Reid R; Sathya J
    Radiother Oncol; 2005 Jun; 75(3):258-70. PubMed ID: 16299924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiopharmaceuticals in clinical trials.
    Holmes RA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclide therapy in oncology.
    Clarke SE
    Cancer Treat Rev; 1994 Jan; 20(1):51-71. PubMed ID: 8293428
    [No Abstract]   [Full Text] [Related]  

  • 6. Strontium and samarium therapy for bone metastases from prostate carcinoma.
    Dickie GJ; Macfarlane D
    Australas Radiol; 1999 Nov; 43(4):476-9. PubMed ID: 10901963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer therapy using bone-seeking isotopes.
    Lewington VJ
    Phys Med Biol; 1996 Oct; 41(10):2027-42. PubMed ID: 8912378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioisotopes for metastatic bone pain.
    Roqué I Figuls M; Martinez-Zapata MJ; Scott-Brown M; Alonso-Coello P
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003347. PubMed ID: 21735393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted radionuclide therapy for bone metastases.
    Lewington VJ
    Eur J Nucl Med; 1993 Jan; 20(1):66-74. PubMed ID: 7678397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Radioisotopes for metastatic bone pain.
    Roqué I Figuls M; Martinez-Zapata MJ; Scott-Brown M; Alonso-Coello P
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD003347. PubMed ID: 28334435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic radiotherapy: what role will it have in 2001?].
    George B; Douard MC; Rain JD
    Cancer Radiother; 2002 May; 6(3):188-200. PubMed ID: 12116845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
    Rubini G; Nicoletti A; Rubini D; Asabella AN
    Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radionuclide therapy of intractable bone pain: emphasis on strontium-89.
    Robinson RG; Preston DF; Spicer JA; Baxter KG
    Semin Nucl Med; 1992 Jan; 22(1):28-32. PubMed ID: 1589803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Palliative treatment of metastasic bone pain].
    Pons F; Fuster D; Vidal-Sicart S
    Rev Esp Med Nucl; 2003 Nov; 22(6):429-38. PubMed ID: 14588238
    [No Abstract]   [Full Text] [Related]  

  • 15. [Radionuclide therapy for painful bone metastases].
    Szefer J; Zuchora Z
    Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
    Krishnamurthy GT; Krishnamurthy S
    J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
    [No Abstract]   [Full Text] [Related]  

  • 17. Unsealed source therapy of painful bone metastases: an update.
    McEwan AJ
    Semin Nucl Med; 1997 Apr; 27(2):165-82. PubMed ID: 9144858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of painful bone metastases with an emphasis on radionuclide therapy.
    Hillegonds DJ; Franklin S; Shelton DK; Vijayakumar S; Vijayakumar V
    J Natl Med Assoc; 2007 Jul; 99(7):785-94. PubMed ID: 17668645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective.
    Montebello JF; Hartson-Eaton M
    Cancer Invest; 1989; 7(2):139-60. PubMed ID: 2477119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153.
    Guerra Liberal FDC; Tavares AAS; Tavares JMRS
    Appl Radiat Isot; 2016 Apr; 110():87-99. PubMed ID: 26773820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.